850102 | 16:0 Lyso PI
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt)

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
16:0 Lyso PI
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt)
Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.
CAS Registry Number is a Registered Trademark of the American Chemical Society
PI(16:0/0:0)
110717
Helsley RN, Varadharajan V, Brown AL, Gromovsky AD, Schugar RC, Ramachandiran I, Fung K, Kabbany MN, Banerjee R, Neumann CK, Finney C, Pathak P, Orabi D, Osborn LJ, Massey W, Zhang R, Kadam A, Sansbury BE, Pan C, Sacks J, Lee RG, Crooke RM, Graham MJ, Lemieux ME, Gogonea V, Kirwan JP, Allende DS, Civelek M, Fox PL, Rudel LL, Lusis AJ, Spite M, Brown JM. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. Elife. 2019 Oct 17;8. pii: e49882. doi: 10.7554/eLife.49882.
PubMed ID: 31621579- Certificate of Analysis (Lot No. 850102P-100UG-C-010 and 5588PDC010)
- Certificate of Analysis (Lot No. 850102P-500UG-B-010 and 5588PFB010)
- Certificate of Analysis (Lot No. 850102P-100UG-D-010 and 5588PDD010)
- Certificate of Analysis (Lot No. 850102P-100UG-A-011 and 5588PDA011)